Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
15 Februar 2024 - 7:15PM
AllPennyStocks.com
Orphan drug designation, or ODD, is valuable on both a
humanitarian and a profitability basis. And this company is seeing
shares rally following news that it was granted the designation for
the...
To read the full story on AllPennyStocks.com, click
here.
Cardiol Therapeutics (TSX:CRDL)
Historical Stock Chart
Von Feb 2025 bis Mär 2025
Cardiol Therapeutics (TSX:CRDL)
Historical Stock Chart
Von Mär 2024 bis Mär 2025